If this is what the secret squirrel stuff some were going on about earlier in the week, it is a bit of a fizzer .... good to see the patent granted but realistically it is not like it wasn't expected ? I mean who else were they going to award the patent to for DEP® cabazitaxel ?
It's not like Sanofi could dispute it as they don't own the DEP technology and let's face it, Starpharma didn't even nominate the announcement as price sensitive for the reasons I have outlined above
I guess we will see if Sanofi are interested enough in it to sign a deal whenever the trials finish next year (or the year after knowing SPL)... we all know how DEP® Remdesivir went - JF is still waiting for Gilead to return her call IMO ?
- Forums
- ASX - By Stock
- Ann: US patent issued for DEP cabazitaxel nanoparticle
If this is what the secret squirrel stuff some were going on...
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.003(3.30%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.2¢ | 9.4¢ | 9.2¢ | $28.85K | 309.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28383 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 17763 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28383 | 0.092 |
2 | 123413 | 0.091 |
2 | 52750 | 0.090 |
2 | 97420 | 0.089 |
1 | 73255 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 98486 | 6 |
0.099 | 1285 | 1 |
0.100 | 127534 | 5 |
0.105 | 19523 | 2 |
0.110 | 16500 | 2 |
Last trade - 11.22am 26/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online